Papers
1
Total Citations
24
H-Index
1
About
Chengxi Li is an emerging researcher specializing in the intersection of synthetic chemistry and pharmaceutical innovation, with a particular focus on automated flow chemistry as a transformative tool for drug synthesis. Their most notable contribution, the 2023 review "Recent developments of automated flow chemistry in pharmaceutical compounds synthesis," has already garnered 24 citations — a remarkable achievement for a recently published work, signaling strong interest and relevance within the scientific community. This work positions Li as a knowledgeable voice in the growing field of continuous flow processing, which promises to revolutionize how pharmaceutical compounds are manufactured by improving reaction efficiency, scalability, safety, and reproducibility compared to traditional batch methods. By systematically mapping recent advances in automated flow systems, Li has provided researchers and pharmaceutical scientists with a valuable roadmap for adopting these cutting-edge technologies. Their research sits at a critical juncture between chemistry, automation, and drug development, making it highly pertinent to both academic laboratories and industrial pharmaceutical production. Li's work represents an important contribution to the modernization of synthetic chemistry workflows.
Research Focus
Key Achievements
Top Papers
- 1